First-line pembrolizumab plus chemotherapy for advanced/metastatic esophageal cancer: 1-year extended follow-up in the Japanese subgroup of the phase 3 KEYNOTE-590 study.

Ken KatoTakashi KojimaHiroki HaraAkihito TsujiHisateru YasuiKei MuroTaroh SatohTakashi OgataRyu IshiharaMasahiro GotoHideo BabaTomohiro NishinaShiRong HanKeiichi IwakamiNaoyoshi YatsuzukaToshihiko Doi

Published in: Esophagus : official journal of the Japan Esophageal Society (2024)

ClinicalTrials.gov, NCT03189719.

Keyphrases

squamous cell carcinoma
small cell lung cancer
clinical trial
radiation therapy
advanced non small cell lung cancer
phase ii
phase iii
open label
rectal cancer
tyrosine kinase